|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhang J, Yu H, Zhang Y, Zhang X, Zheng G,
Gao Y, Wang C and Zhou L: A functional TNFAIP2 3'-UTR rs8126
genetic polymorphism contributes to risk of esophageal squamous
cell carcinoma. PLoS One. 9(e109318)2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Toh Y, Egashira A and Yamamoto M:
Epigenetic alterations and their clinical implications in
esophageal squamous cell carcinoma. Gen Thorac Cardiovasc Surg.
61:262–269. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wang M, Smith JS and Wei WQ: Tissue
protein biomarker candidates to predict progression of esophageal
squamous cell carcinoma and precancerous lesions. Ann N Y Acad Sci.
1434:59–69. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hua Y, Zhao K, Tao G, Dai C and Su Y:
miR-25 promotes metastasis via targeting FBXW7 in esophageal
squamous cell carcinoma. Oncol Rep. 38:3030–3038. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Du YY, Zhao LM, Chen L, Sang MX, Li J, Ma
M and Liu JF: The tumor-suppressive function of miR-1 by targeting
LASP1 and TAGLN2 in esophageal squamous cell carcinoma. J
Gastroenterol Hepatol. 31:384–393. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhu Y, Ma Y, Peng H, Gong L, Xiao M, Xiang
L, He D and Cao K: MiR-130b promotes the progression of oesophageal
squamous cell carcinoma by targeting SASH1. J Cell Mol Med.
23:93–103. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yu X, Li W, Xia Z, Xie L, Ma X, Liang Q,
Liu L, Wang J, Zhou X, Yang Y and Liu H: Targeting MCL-1 sensitizes
human esophageal squamous cell carcinoma cells to cisplatin-induced
apoptosis. BMC Cancer. 17(449)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang SY, Zhang SW, Fan XN, Meng J, Chen
Y, Gao SJ and Huang Y: Global analysis of N6-methyladenosine
functions and its disease association using deep learning and
network-based methods. PLoS Comput Biol.
15(e1006663)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lin S, Choe J, Du P, Triboulet R and
Gregory RI: The m(6)A methyltransferase METTL3 promotes translation
in human cancer cells. Mol Cell. 62:335–345. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang
L, Jia G, Yu M, Lu Z, Deng X, et al: A METTL3-METTL14 complex
mediates mammalian nuclear RNA N-6-adenosine methylation. Nat Chem
Biol. 10:93–95. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ping XL, Sun BF, Wang L, Xiao W, Yang X,
Wang WJ, Adhikari S, Shi Y, Lv Y, Chen YS, et al: Mammalian WTAP is
a regulatory subunit of the RNA N6-methyladenosine
methyltransferase. Cell Res. 24:177–189. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Schwartz S, Mumbach MR, Jovanovic M, Wang
T, Maciag K, Bushkin GG, Mertins P, Ter-Ovanesyan D, Habib N,
Cacchiarelli D, et al: Perturbation of m6A writers reveals two
distinct classes of mRNA methylation at internal and 5' sites. Cell
Rep. 8:284–296. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lin S, Liu J, Jiang W, Wang P, Sun C, Wang
X, Chen Y and Wang H: METTL3 promotes the viability and mobility of
gastric cancer cells. Open Med (Wars). 14:25–31. 2019.
|
|
16
|
Wei W, Huo B and Shi X: miR-600 inhibits
lung cancer via downregulating the expression of METTL3. Cancer
Manag Res. 11:1177–1187. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cheng M, Sheng L, Gao Q, Xiong Q, Zhang H,
Wu M, Liang Y, Zhu F, Zhang Y, Zhang X, et al: The m6A
methyltransferase METTL3 promotes bladder cancer progression via
AFF4/NF-κB/MYC signaling network. Oncogene. 38:3667–3680.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hua W, Zhao Y, Jin X, Yu D, He J, Xie D
and Duan P: METTL3 promotes ovarian carcinoma growth and invasion
through the regulation of AXL translation and epithelial to
mesenchymal transition. Gynecol Oncol. 151:356–365. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Taketo K, Konno M, Asai A, Koseki J,
Toratani M, Satoh T, Doki Y, Mori M, Ishii H and Ogawa K: The
epitranscriptome m6A writer METTL3 promotes chemo- and
radioresistance in pancreatic cancer cells. Int J Oncol.
52:621–629. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Dahal U, Kang L and Gupta M: RNA m6A
methyltransferase METTL3 regulates invasiveness of melanoma cells
by matrix metallopeptidase 2. Melanoma Res. 29:382–389.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cai X, Wang X, Cao C, Gao Y, Zhang S, Yang
Z, Liu Y, Zhang X, Zhang W and Ye L: HBXIP-elevated
methyltransferase METTL3 promotes the progression of breast cancer
via inhibiting tumor suppressor let-7g. Cancer Lett. 415:11–19.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li X, Tang J, Huang W, Wang F, Li P, Qin
C, Qin Z, Zou Q, Wei J, Hua L, et al: The M6A methyltransferase
METTL3: Acting as a tumor suppressor in renal cell carcinoma.
Oncotarget. 8:96103–96116. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Choe J, Lin S, Zhang W, Liu Q, Wang L,
Ramirez-Moya J, Du P, Kim W, Tang S, Sliz P, et al: mRNA
circularization by METTL3-eIF3h enhances translation and promotes
oncogenesis. Nature. 561:556–560. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lin H, Wang Z, Shen J, Xu J and Li H:
Intravenous anesthetic ketamine attenuates complete Freund's
adjuvant-induced arthritis in rats via modulation of MAPKs/NF-κB.
Inflamm Res. 68:147–155. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ouyang G, Xiong L, Liu Z, Lam B, Bui B, Ma
L, Chen X, Zhou P, Wang K, Zhang Z, et al: Inhibition of autophagy
potentiates the apoptosis-inducing effects of photodynamic therapy
on human colon cancer cells. Photodiagnosis Photodyn Ther.
21:396–403. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhou K, Zhang C, Yao H, Zhang X, Zhou Y,
Che Y and Huang Y: Knockdown of long non-coding RNA NEAT1 inhibits
glioma cell migration and invasion via modulation of SOX2 targeted
by miR-132. Mol Cancer. 17(105)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li T, Zhou W, Li Y, Gan Y, Peng Y, Xiao Q,
Ouyang C, Wu A, Zhang S, Liu J, et al: MiR-4524b-5p/WTX/β-catenin
axis functions as a regulator of metastasis in cervical cancer.
PLoS One. 14(e0214822)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang G, Sun J, Zhao H and Li H: Long
non-coding RNA (lncRNA) growth arrest specific 5 (gas5) suppresses
oesophageal squamous cell carcinoma cell proliferation and
migration by inactivating phosphatidylinositol 3-kinase
(PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway.
Med Sci Monit. 24:7689–7696. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
He B, Peng F, Li W and Jiang Y:
Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced
cancer stem cell properties in HepG2 through PI3K/Akt signaling. J
Cell Biochem. 120:2908–2918. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
He Y, Mingyan E, Wang C, Liu G, Shi M and
Liu S: CircVRK1 regulates tumor progression and radioresistance in
esophageal squamous cell carcinoma by regulating
miR-624-3p/PTEN/PI3K/AKT signaling pathway. Int J Biol Macromol.
125:116–123. 2019.PubMed/NCBI View Article : Google Scholar
|
